The University has formed a new partnership with to accelerate drug development across the UK and make it more efficient.
Medidata provides cloud-based platforms for clinical research in life sciences.
, which is part of the UK Clinical Research Collaboration, will use the to conduct more complex and scientifically rigorous clinical research.
SCTU鈥檚 portfolio, supported by core funding from聽 and support funding from the , consists of a diverse set of clinical research studies.
SCTU will use Medidata鈥檚 platform technology to generate high-quality, standardised data that industry partners could use to support late-stage development programmes and drug approval submissions in the UK and US.
鈥淎t the Southampton Clinical Trials Unit, University of Southampton, we pride ourselves on working with the most skilled, experienced partners, investigators and sites to conduct high-quality, efficient trials. This new development could lead to more impactful clinical results that will potentially benefit the future treatment of patients in the UK and further afield,鈥� said , Director of the Southampton CTU.
The full story is available .